Inside Microvascular Decompression: How Trigeminal Neuralgia Surgery Cushions the Nerve

The first thing she stopped doing was brushing her teeth on the left side. Then she stopped eating crusty bread, then talking on the phone with that ear, then going outside when the wind picked up. Each small retreat bought a few hours without the electric jolt that ran from her cheek into her jaw. The medicine that once switched the pain off now mostly made her sleepy, and her neurologist had begun to use a new word: surgery.

For many people with trigeminal neuralgia, that word arrives with a second one they have never heard before. The microvascular decompression procedure, usually shortened to MVD, is the only widely used treatment that tries to fix the mechanical problem thought to drive the pain, rather than deliberately damaging the nerve to quiet it.

What follows is an honest tour of that operation: what the surgeon is actually looking for, what the days afterward usually feel like, where the evidence is strong, and where it is still unsettled.

What is trigeminal neuralgia, and why does a blood vessel matter?

The trigeminal nerve is the fifth of twelve cranial nerves, the paired nerves that leave the brain directly rather than through the spinal cord. It carries sensation from the face in three branches: one to the forehead and eye, one to the cheek and upper jaw, one to the lower jaw. It also drives the muscles you chew with. Most of the time it does this quietly for an entire lifetime.

Trigeminal neuralgia is what happens when that nerve starts firing without a reason. People describe stabbing or shock-like pain on one side of the face, lasting seconds to a couple of minutes, set off by ordinary touch: a razor, a toothbrush, a gust of cold air, a kiss. Between attacks there may be nothing at all, or a dull background ache in the same territory. The NHS and Mayo Clinic both note that the condition is more common in people over fifty and somewhat more common in women, though it can occur at any age.

Where does the misfiring come from? In the most common form, an MRI scan shows a small artery, most often the superior cerebellar artery, looping against the nerve at the point where it enters the brainstem. That entry zone is the nerve’s weak spot. The insulating sheath there is thin and easily worn by decades of pulsation, and once the insulation frays, signals from neighboring fibers can leak into one another. A light touch on the cheek gets misread as a knife.

That mechanism is the whole rationale for the microvascular decompression procedure. If a pulsing vessel is wearing through the nerve’s insulation, moving the vessel away should stop the wear. Not every case fits this picture, which is one reason the decision is never automatic.

How the microvascular decompression procedure actually works

Strip away the technical vocabulary and MVD is an act of rearrangement. Nothing is cut out of the nerve. Nothing is burned, frozen, or injected into it. The surgeon simply changes what is touching it.

The operation is done under general anesthesia. Behind the ear on the painful side, a small area of hair is trimmed and an incision a few inches long is made. Beneath it, a piece of bone about the size of a large coin is removed to create a window into the back of the skull, a step called a craniotomy, meaning a surgical opening in the skull. Through that window, the surgeon works in the narrow space between the cerebellum, the part of the brain that fine-tunes balance and coordination, and the inside of the skull.

Using an operating microscope, and in some centers an endoscope, which is a thin lighted camera, the surgeon follows the trigeminal nerve back to where it meets the brainstem. This is where the offending vessel usually sits. Arteries are gently lifted away, and a small pad of soft synthetic felt is placed between vessel and nerve so the two can no longer rub. When a vein is the culprit, it may be moved or, if small, sealed and divided. The pad stays in place permanently.

Once the nerve lies free, the bone flap or a small plate is replaced, the layers are closed, and the skin is stitched. Patient guides from Johns Hopkins Medicine and Cleveland Clinic describe the operation as typically lasting around two to three hours, although complex anatomy can lengthen that.

What makes MVD distinctive among trigeminal neuralgia surgeries is this preservation of the nerve itself. The other surgical options work by intentionally injuring it. That difference explains both the appeal of MVD and its larger footprint as an operation.

Is microvascular decompression brain surgery?

Yes, though with an important qualification. MVD requires opening the skull and working beside the brain, which makes it neurosurgery in every formal sense. Anesthesia, the operating team, the recovery unit, and the consent process are all those of a brain operation.

What the surgeon does not do is cut into brain tissue. The trigeminal nerve and its troublesome vessel lie in a fluid-filled space at the base of the skull, alongside the cerebellum rather than inside it. The cerebellum is gently held aside, not entered. Surgeons sometimes describe this as surgery around the brain rather than in it, and that distinction matters for what recovery looks like.

Still, the setting brings real risks that a purely peripheral procedure would not, and it helps to name them plainly. The nerves for hearing and facial movement travel through the same crowded corridor, millimeters from the trigeminal nerve. The brainstem, which controls breathing and heart rate, is the backdrop to the whole operation. Cerebrospinal fluid, the clear liquid that bathes the brain and spinal cord, must be kept sealed inside once the closure is complete. Each of these is a place where something can go wrong, and each is discussed in the risks section below.

Why does the question come up so often? Partly because trigeminal neuralgia feels like a dental or facial problem, not a neurological one, so people are startled to learn the fix is behind the ear. Partly because the alternatives, needle procedures through the cheek or focused radiation with no incision at all, sound so much smaller. They are smaller. They are also, by design, procedures that damage the nerve. Choosing between a larger operation that spares the nerve and a lesser one that injures it is the central trade-off, and only the treating team can weigh it for an individual.

Who is usually offered MVD surgery for trigeminal neuralgia, and who is asked to wait

Surgery is rarely the first step. The NHS, Mayo Clinic, and the National Institute of Neurological Disorders and Stroke all describe medicine as the starting point, most often an anticonvulsant of the carbamazepine class, drugs originally developed for epilepsy that calm overactive nerve firing. Many people are controlled on medicine for years. Choices about which drug, how much, and for how long belong to the prescribing clinician.

The conversation about MVD typically opens when one of a few things happens:

• Pain breaks through despite medicine that is being taken as prescribed.
• The side effects of effective doses, such as drowsiness, unsteadiness, or slowed thinking, become harder to live with than the condition they are treating.
• Blood tests show the medicine is affecting the liver, blood counts, or sodium levels.
• The person is young enough that decades of escalating medication seem a poor bargain.

Surgeons also look for a picture that fits the operation. Classic, shock-like attacks on one side with a vessel visibly touching the nerve on a high-resolution MRI make the strongest case. General fitness for anesthesia matters, since this is a lengthy operation in the prone or side-lying position.

Who is usually asked to wait or steered elsewhere? People whose scans show no vessel contact, since there may be nothing to move. People whose trigeminal neuralgia stems from multiple sclerosis, where the damage is inside the brainstem itself and MVD is generally less useful. People with constant, burning, or bilateral facial pain, patterns that the NINDS notes respond less predictably to any surgery. And people with serious heart or lung disease for whom a shorter procedure under sedation carries less risk. None of these are absolute rules; they are the starting points for a discussion.

Before the operation: scans, medicines and the consent conversation

The most important preoperative test is the one that decides whether MVD makes sense at all. A dedicated MRI of the posterior fossa, the compartment at the back of the skull, is performed with thin slices and special sequences that show nerves and vessels as distinct structures. The radiologist and surgeon look for the point of contact, note which vessel is involved, and check for anything else that could mimic trigeminal neuralgia, such as a tumor pressing on the nerve or the plaques of multiple sclerosis. Mayo Clinic lists both as conditions the scan is meant to exclude.

A pre-anesthesia assessment follows: heart tracing, blood tests, a review of every medicine and supplement. Blood-thinning drugs and some over-the-counter painkillers affect clotting and will need a plan, but the timing of any pause is set by the surgical and prescribing team, never by the patient alone. The same is true of the trigeminal neuralgia medicine itself; people are usually told to keep taking it up to the day of surgery and are given instructions about what happens afterward.

Hearing is often tested before the operation because the hearing nerve is a close neighbor of the trigeminal nerve, and a baseline lets the team measure any change.

Then comes the consent conversation, which deserves more time than it sometimes gets. A good one covers what the surgeon expects to find, what happens if no compressing vessel is seen once the skull is open, the realistic possibility that pain may return years later, and the specific complications listed on the form. Patients are entitled to ask how many of these operations the surgeon performs and what their own complication experience has been; those are reasonable questions, not rude ones. Bringing a second person to listen and take notes is worth the awkwardness of asking.

Step by step: what happens during the microvascular decompression procedure

Walking through the operation in order removes some of its mystery. Every team has its own variations, but the sequence below reflects how the microvascular decompression procedure is generally described in patient guides from Cleveland Clinic and Johns Hopkins Medicine.

Positioning. After anesthesia, the person is placed on their side or face-down with the head held in a padded frame so the surgeon can look directly along the nerve’s path. The skin behind the ear is cleaned and a strip of hair trimmed; a full head shave is not needed.

Opening. A curved incision is made behind the ear and the muscles of the neck are eased aside. A small opening is drilled in the bone just behind the ear’s mastoid bump, then widened to expose the dura, the tough membrane covering the brain. The dura is opened and a little cerebrospinal fluid is allowed to drain, which relaxes the cerebellum and creates working room.

Exposure. Under the microscope, the surgeon advances along the underside of the cerebellum toward the brainstem, identifying landmarks: the petrosal vein, the hearing and facial nerves, and then the trigeminal nerve itself, which appears as a pale cord about the width of a pencil lead. Monitoring electrodes placed at the start track hearing and facial nerve signals throughout, so any strain on those nerves is flagged immediately.

Decompression. The offending vessel is freed from any fine membranes tethering it, lifted off the nerve, and held away with one or more pads of synthetic felt. The surgeon inspects the whole length of the nerve because more than one vessel is sometimes involved.

Closure. The dura is sewn shut and often sealed with a glue or graft, the bone opening is covered with the original bone or a small plate, and the skin is closed with stitches or staples.

How painful is microvascular decompression surgery?

People almost always mean two different things by this question, so it helps to separate them.

The first is the operation itself, which is not felt at all. General anesthesia means the person is fully unconscious, with breathing supported and pain signals blocked, from before the first incision until after the last stitch.

The second is what the days afterward feel like, and here honesty serves better than reassurance. The most common complaint is a headache, often described as a deep ache at the back of the head on the operated side, made worse by sitting up quickly. It comes from the muscles that were moved, the bone that was opened, and the change in cerebrospinal fluid pressure as the space around the brain resettles. Neck stiffness is common for the same reasons. Nausea in the first day or two is frequent because the cerebellum, which sits next to the brain’s balance circuitry, has been gently handled. Cleveland Clinic’s patient information lists headache, nausea, and incision discomfort as the expected early symptoms.

Pain after surgery is managed by the ward team with a plan set before the operation, and people are encouraged to describe it rather than endure it, since uncontrolled pain slows mobilization. The choice and amount of pain medicine, and how quickly it is stepped down, is a clinical decision made bedside.

The other side of this question is what people notice is absent. Many report that the shock-like facial pain is gone or greatly diminished when they wake, which can be startling after years of guarding one side of the face. Others find it fades over days. Mayo Clinic notes that relief is common but that pain can return in some people over time, so the early result is a beginning, not a verdict.

Microvascular decompression hospital stay: the first two or three days

The first night is usually spent in a neurosurgical high-dependency or intensive care unit, not because trouble is expected but because it is the place where trouble would be caught fastest. Nurses check pupils, limb strength, speech, and alertness on a schedule through the night. A headache and a sore neck are expected; a new weakness or confusion is not, and the point of that first night is telling one from the other.

By the next morning most people are sitting up, sipping fluids, and taking their first steps with a nurse or physiotherapist alongside. Early walking matters for the same reasons it does after any operation: it keeps the lungs expanded and reduces the chance of a blood clot forming in the legs. Dizziness and unsteadiness are common on those first walks and are a reason for supervision, not alarm.

Over the following day or two, the intravenous lines come out, pain medicine moves to tablets, and the team watches for the specific things that would change the plan: clear fluid leaking from the wound or the nose, a fever, hearing that seems muffled on the operated side, or new facial numbness. Most people are eating normal food and walking the corridor independently before discharge.

Patient guides from Johns Hopkins Medicine and Cleveland Clinic describe a typical hospital stay of around two to three days, though the actual length is set by how each person recovers rather than by a calendar. Discharge usually comes with written instructions about wound care, which activities to avoid, how to manage the trigeminal neuralgia medicine, and whom to call. Any change to the neuralgia medicine, including whether and how to reduce it now that the nerve has been decompressed, is planned by the prescribing clinician and often happens gradually over the following weeks.

Microvascular decompression recovery time, week by week

Recovery from MVD tends to follow a recognizable arc, even though the pace varies from person to person. The ranges below are drawn from patient guidance published by Cleveland Clinic and Johns Hopkins Medicine and should be read as typical, not guaranteed.

The first week at home. Fatigue dominates. The head and neck ache, and turning the head or bending forward tends to bring on a throb. Short walks around the house several times a day are encouraged; lifting, straining, and bending are not. The incision is kept clean and dry as instructed, and hair washing resumes when the team says so.

Weeks two and three. Energy begins to return in stretches rather than all at once. Many people find they can read, cook, and take longer walks but still need an afternoon rest. Headache usually eases week by week. Stitches or staples, if not dissolvable, are removed around this time at a wound check.

Weeks four to six. This is the window in which published guidance suggests most people are back to routine activities, including desk-based work, driving once the surgeon and local regulations allow, and gentle exercise. Heavy lifting and contact sports typically wait longer.

Beyond six weeks. Residual numbness of the scalp around the incision and occasional tenderness where bone was removed can persist for months and usually fade slowly. Some people notice a patch of reduced feeling on the face, which may settle or may be permanent.

Two things shape the timeline more than any others: age and general fitness before surgery, and whether any complication occurred. Someone in their forties with no other health problems and an uneventful operation is likely to be at the faster end; someone in their late seventies recovering from a fluid leak will need longer. Neither is failing at recovery. Both are recovering.

Risks and complications in plain clinical language

Every surgical consent form for MVD lists a set of possible harms, and the list is long precisely because the anatomy is crowded. Setting them out clearly is not fear-mongering; it is the information the decision rests on.

Hearing loss on the operated side. The hearing nerve runs alongside the trigeminal nerve and can be stretched during exposure. Intraoperative monitoring reduces this risk but cannot remove it. Loss may be partial or complete and is sometimes permanent. Mayo Clinic and the NINDS both list it among the recognized complications.

Facial numbness. Handling the nerve can leave a patch of reduced sensation, most often on the cheek or jaw. In MVD this is less frequent than after procedures that deliberately injure the nerve, but it happens.

Cerebrospinal fluid leak. If the seal of the dura is incomplete, fluid can escape through the wound or into the ear and nose. Some leaks settle with bed rest; others need a further procedure to close.

Infection and meningitis. Any breach of the skull carries a small risk of wound infection or of infection of the membranes around the brain, which is treated with antibiotics and sometimes further surgery.

Facial weakness, double vision, or balance problems. These arise from strain on neighboring nerves or the cerebellum and are usually temporary.

Stroke, brain hemorrhage, or death. Rare, but real, as with any operation near the brainstem. Mayo Clinic explicitly lists stroke among possible complications.

Anesthetic risks and blood clots. Common to all major surgery.

How often do these occur? Published series vary widely by center and by how complications are defined, and this article does not quote figures that cannot be tied to a named guideline or systematic review. Ask your surgeon for their own numbers; that is the most relevant data you can get.

How MVD compares with other trigeminal neuralgia treatments

The honest way to understand MVD is next to its alternatives. Each option below is described neutrally; none is a recommendation, and the right fit depends on scan findings, age, health, and preferences discussed with the treating team.

Treatment	What it does	Setting	Nerve preserved?	Commonly noted trade-offs
Anticonvulsant medicine (carbamazepine class)	Dampens abnormal nerve firing	Outpatient, ongoing	Yes	Drowsiness, unsteadiness; blood monitoring; effect may wane over years
Microvascular decompression	Moves the compressing vessel and pads the nerve	General anesthesia, craniotomy, inpatient stay	Yes	Largest operation; hearing loss, fluid leak, rare stroke; pain can recur
Percutaneous procedures (glycerol injection, balloon compression, radiofrequency lesion)	Deliberately injures part of the nerve via a needle through the cheek	Sedation or brief anesthesia, often same-day	No	Facial numbness expected; relief often shorter; repeatable
Stereotactic radiosurgery	Focused radiation to the nerve root, no incision	Outpatient	No	Relief delayed by weeks to months; numbness may develop later

Three patterns emerge from this table and from guidance published by the NHS and NINDS. First, MVD is the only option that neither sedates the nervous system nor damages the nerve, which is why it is often preferred for younger, fit people with clear vessel contact on MRI. Second, the destructive procedures buy smaller operations at the price of numbness and, frequently, shorter-lived relief, though they can be repeated and are often chosen for frailer patients. Third, none of these treatments works for everyone or forever. The NHS describes MVD as the option generally thought to offer the longest-lasting relief, while acknowledging that pain can return and that the operation carries risks the others do not. That balanced framing is a fair summary of where the evidence stands.

What people often get wrong about microvascular decompression

Myths about MVD tend to cluster at two extremes: that it is a minor procedure, or that it is a miracle. The evidence supports neither.

“It’s a small keyhole operation.” The incision is modest and the bone window is coin-sized, but the surgeon is working beside the brainstem under general anesthesia for hours. Recovery is measured in weeks, not days. Calling it minor sets people up for a hard first fortnight.

“Once the vessel is moved, the pain is gone for good.” Many people do get lasting relief, and Mayo Clinic notes MVD can eliminate or reduce pain in most cases. It also notes that pain can recur. Vessels can shift, pads can migrate, new contact points can develop, and some nerves are already too damaged to fully quiet down. Anyone promising permanence is not reading the same literature as the guidelines.

“If the scan shows a vessel touching the nerve, surgery will definitely work.” Vessel contact is common in people without any facial pain at all. It strengthens the case, but the diagnosis is made from the story of the pain, not the picture.

“Numbness afterward means the operation failed.” Some facial numbness can follow MVD even when pain relief is excellent. It is a side effect, not a verdict.

“You can stop the medicine as soon as you wake up.” Abruptly stopping anticonvulsants carries its own risks. Reductions are planned and gradual and belong to the prescribing clinician.

“Trigeminal neuralgia is a dental problem.” Perhaps the costliest myth. Many people undergo extractions or root canals before the diagnosis is made, because the pain sits in the teeth. The NHS specifically flags this pattern. Shock-like pain that does not match a dental finding deserves a neurological opinion before more dentistry.

Questions to ask your care team

A surgical consultation moves fast, and the questions that matter most are often the ones that occur to people in the car park afterward. Writing them down beforehand changes the conversation. These are the ones that tend to surface the most useful answers.

• On my MRI, do you see a vessel touching the nerve? Which one, and how confident are you that it is the cause?
• Do my symptoms fit the classic pattern that responds best to MVD, or are there features that make you less certain?
• What will you do if you open the skull and find no clear compression?
• How many of these operations do you perform each year, and what have your own complication rates been for hearing loss, fluid leak, and infection?
• Will hearing and facial nerve monitoring be used during my operation?
• What is your plan for my trigeminal neuralgia medicine before and after surgery, and who manages the reduction?
• Which of my other medicines need to stop or change, and when?
• How long do you expect me to be in hospital, and what would extend that?
• What symptoms in the first weeks should make me call you immediately?
• When can I drive, return to work, fly, and exercise?
• If the pain returns years from now, what options would remain open to me?
• Are there reasons a percutaneous procedure or radiosurgery might be a better fit for me specifically?

None of these questions is a challenge to the surgeon’s competence. Experienced teams welcome them, because patients who understand the plan recover more confidently and notice problems sooner. If an answer is vague, ask again. If a question is waved away, that in itself is information worth weighing.

It also helps to ask who your point of contact is after discharge. Recovery happens at home, and knowing which number to call at nine o’clock on a Sunday evening is as practical a piece of preparation as anything on the consent form.

When to call your doctor

Most of what people feel after MVD, the headache, the stiff neck, the tiredness, the mild dizziness, is expected and eases with time. A short list of symptoms is different. These warrant a same-day call to the surgical team, or emergency care if the team cannot be reached.

Call urgently or seek emergency care for:

• Clear or watery fluid leaking from the incision, the nose, or the ear, or a salty taste at the back of the throat, which can signal a cerebrospinal fluid leak.
• Fever with a stiff neck, worsening headache, sensitivity to light, or confusion, which together can indicate meningitis.
• A wound that becomes increasingly red, swollen, hot, or discharges pus, or whose edges begin to gape.
• Sudden new weakness or numbness of an arm or leg, facial drooping, slurred speech, or trouble swallowing.
• A headache that is abruptly severe or unlike the postoperative ache, especially with vomiting or drowsiness.
• New or worsening hearing loss, ringing, or spinning vertigo that prevents walking.
• Double vision that appears or worsens after discharge.
• A swollen, painful calf, or breathlessness and chest pain, which can indicate a blood clot.
• A seizure of any kind.

Call in the next working day for headaches that are not improving week on week, facial numbness that is spreading, an eye on the operated side that feels dry or gritty, or any return of shock-like facial pain. The last of these is not necessarily a sign that the operation has failed; the team will want to know so they can plan.

Anyone with trigeminal neuralgia who has not yet had surgery should also seek prompt advice if attacks become continuous, if numbness or weakness of the face develops, if pain appears on both sides, or if there are new problems with vision, balance, or speech. These features can point to a cause other than a compressing vessel and change the whole plan.

Frequently asked questions

How painful is microvascular decompression surgery?

The operation itself is painless because it is performed under general anesthesia. Afterward, the most common complaints are a headache at the back of the head, neck stiffness, incision soreness, and nausea in the first day or two. These are managed by the ward team and typically ease over the first two to three weeks according to Cleveland Clinic patient guidance. Many people notice the shock-like facial pain is reduced or absent soon after waking.

How long does it take to recover from microvascular decompression surgery?

Published patient guides from Johns Hopkins Medicine and Cleveland Clinic describe a return to most routine activities within about four to six weeks, with the first two weeks dominated by fatigue and headache. Heavy lifting and contact sport usually wait longer. Scalp numbness near the incision can persist for months. Age, fitness before surgery, and whether any complication occurred are the main factors that stretch or shorten this timeline.

Is microvascular decompression considered brain surgery?

Yes. MVD involves opening the skull and operating beside the brainstem and cerebellum, so it is neurosurgery with the anesthesia, monitoring, and risks that implies. The surgeon does not cut into brain tissue, however; the trigeminal nerve and its compressing vessel sit in a fluid-filled space that is reached by gently holding the cerebellum aside. That distinction is why recovery is usually measured in weeks rather than months.

How long do you usually stay in hospital for microvascular decompression of the trigeminal nerve?

A typical microvascular decompression hospital stay is around two to three days, according to patient guidance from Johns Hopkins Medicine and Cleveland Clinic. The first night is usually spent in a high-dependency or intensive care unit for close neurological checks. Discharge depends on walking safely, eating, having pain controlled on tablets, and showing no signs of fluid leak or infection, rather than on a fixed number of nights.

What is the microvascular decompression recovery time before returning to work?

For desk-based work, many people return within the four-to-six-week window described in Cleveland Clinic and Johns Hopkins Medicine guidance, sometimes on reduced hours at first. Physically demanding jobs involving lifting or straining usually require longer and a specific clearance from the surgical team. Fatigue and headache, not the incision, are what most often delay a return, so building in flexibility is sensible.

Will trigeminal neuralgia pain come back after MVD surgery?

It can. Mayo Clinic notes that MVD eliminates or reduces pain in most people but that pain recurs in some over time. Vessels can shift, the padding can move, or the nerve may have been damaged too long to fully recover. The NHS describes MVD as generally offering the longest-lasting relief among surgical options while making the same caveat. Recurrence does not close off further treatment; several options usually remain.

What happens if the surgeon finds no blood vessel pressing on the nerve?

This is a scenario worth discussing before surgery, because it does occur. Some surgeons will still free the nerve of any fine membranes, others may perform a controlled partial injury to the nerve, and some will simply close. Each approach has different implications for numbness and relief. Ask your surgeon which they would choose in your case and why; the answer should be part of your informed consent.

Do I have to stop my trigeminal neuralgia medicine after MVD?

Not on your own, and not suddenly. Anticonvulsant medicines are usually continued around the time of surgery and then reduced gradually under the direction of the prescribing clinician if pain relief holds. Abrupt withdrawal carries its own risks. The timing and pace of any reduction are individual decisions, and some people remain on a lower amount for a period while the nerve settles.

Can MVD be done with an endoscope instead of a microscope?

Some surgeons use an endoscope, a thin lighted camera, either alongside or instead of the operating microscope. It can improve the view around corners at the nerve’s root without a larger opening. The principles of the operation, moving the vessel and padding the nerve, are unchanged, and the bone window and general anesthesia are still required. Whether it changes outcomes compared with the microscope is not settled by high-quality comparative evidence.

Who should not have microvascular decompression for trigeminal neuralgia?

MVD is generally not favored when MRI shows no vessel contacting the nerve, when the neuralgia is caused by multiple sclerosis, when pain is constant and burning rather than shock-like, or when serious heart or lung disease makes a long general anesthetic unwise. In those situations, medicine adjustments, percutaneous needle procedures, or stereotactic radiosurgery may be discussed instead. The final judgment rests with the neurologist and neurosurgeon together.

References

• NHS: Trigeminal neuralgia: Treatment
• NIH National Institute of Neurological Disorders and Stroke: Trigeminal Neuralgia
• MedlinePlus: Trigeminal neuralgia

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.